Q BankQuestion BankDocsDocuments

C3.2.8—B-lymphocyte activation

B-lymphocyte activation explains how a specific barrier, pathogen interaction, immune mechanism or treatment response contributes to protection against infectious disease.

Syllabus
First assessment 2025
Objective
C3.2.8
Level
HL

Exam analysis

Chance of appearing8%of analysed past papers
Latest appearanceNovember 2025
Most common paperPaper2
Typical marks1–7

Common command terms

  • Identify
  • Describe
  • Explain
  • Outline

Scoring notes

Common mistake
Confusing plasma cells, memory cells and helper T-cells in the activation sequence.

Recent exam appearances

November 2025Paper1A ["HL"] · TZ326[ 1 ]C3.2.8—B-lymphocyte activation
May 2024Paper1 ["HL"] · TZ138[ 1 ]C3.2.8—B-lymphocyte activation
November 2021Paper2 ["HL"] · TZ08(b)[ 7 ]C3.2.8—B-lymphocyte activation
May 2021Paper2 ["HL"] · TZ14(a)[ 3 ]C3.2.8—B-lymphocyte activation
May 2019Paper2 ["HL"] · TZ11(g)[ 3 ]C3.2.8—B-lymphocyte activation
Practice this objective

Coverage 2013–2025 · Updated 16 Jul 2026

Concept essentials

  • B-lymphocyte activation has to be linked to the exact pathogen, cell, molecule or population process involved.
  • The biological effect of b-lymphocyte activation depends on the sequence from trigger to protective outcome.
  • Clear distinctions within b-lymphocyte activation prevent confusion with neighbouring immune responses.
  • Evidence for b-lymphocyte activation is strongest when mechanism and consequence are explained together.
ConceptIB Biology HL